Is neoadjuvant androgen deprivation therapy beneficial in prostate cancer treated with definitive radiotherapy?
Radiation Oncology Journal. 2014;32(4):247 
71 CARDIOVASCULAR MORTALITY (CV) AMONG PROSTATE CANCER PATIENTS (PCa) TREATED RADICALLY WITH EXTERNAL BEAM RADIATION THERAPY (EBRT) WITH AND WITHOUT NEOADJUVANT ANDROGEN DEPRIVATION THERAPY (NADT)
Radiotherapy and Oncology. 2009;92:S23
904 Poster Radiotherapy of prostate cancer — acute toxicity without and with neoadjuvant androgen deprivation
Radiotherapy and Oncology. 2002;64:S267
195 poster The impact of prostate volume and neoadjuvant androgen deprivation therapy on urinary function following prostate brachytherapy
Radiotherapy and Oncology. 2004;71:S89
Androgen deprivation therapy and depression in men with prostate cancer treated with definitive radiation therapy: A psychological perspective
Cancer. 2019;125(7):1027-1029
Recovery of serum testosterone after neoadjuvant androgen deprivation therapy and radical radiotherapy in localized prostate cancer
Yearbook of Oncology. 2007;2007:129-130
Androgen deprivation therapy and acute kidney injury in patients with prostate cancer undergoing definitive radiotherapy
Prostate Cancer and Prostatic Diseases. 2021;
249P Optimal duration of neoadjuvant androgen deprivation therapy for prostate volume reduction in locally advanced prostate cancer radiotherapy
Annals of Oncology. 2015;26:ix71
Androgen deprivation therapy in men with prostate cancer: how should the side effects be monitored and treated?
Clinical Endocrinology. 2011;74(3):289-293
Androgen deprivation therapy as adjuvant/neoadjuvant to radiotherapy for high-risk localised and locally advanced prostate cancer: recent developments
British Journal of Cancer. 2011;105(11):1628-1634